INFINIUM — Infinium Pharmachem Balance Sheet
0.000.00%
- IN₹3.74bn
- IN₹4.08bn
- IN₹1.56bn
- 38
- 23
- 36
- 19
Annual balance sheet for Infinium Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19.9 | 54.5 | 59.8 | 119 | 348 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 135 | 203 | 222 | 261 | 414 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 255 | 437 | 513 | 650 | 1,399 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 85.8 | 127 | 188 | 197 | 216 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 342 | 590 | 706 | 855 | 1,984 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 212 | 315 | 368 | 174 | 636 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 272 | 459 | 481 | 267 | 889 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 70.2 | 131 | 226 | 588 | 1,095 |
| Total Liabilities & Shareholders' Equity | 342 | 590 | 706 | 855 | 1,984 |
| Total Common Shares Outstanding |